Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
03/31/1994 | WO1994006814A1 Ikaros: a t cell pathway regulatory gene |
03/31/1994 | WO1994006812A1 Green fluorescent labeled nucleotides for use in probes |
03/31/1994 | WO1994006811A1 Siloxy oligonucleotide analogs |
03/31/1994 | WO1994006810A1 Oligonucleotides having universal nucleoside spacers |
03/31/1994 | WO1994003611A3 Ptp-d subfamily of protein tyrosine phosphatases |
03/31/1994 | CA2145412A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
03/31/1994 | CA2145092A1 Conjugate for the detection and/or assay of a biological compound |
03/31/1994 | CA2145063A1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
03/31/1994 | CA2144334A1 Oligonucleotides having universal nucleoside spacers |
03/31/1994 | CA2123406A1 Ikaros: a t cell pathway regulatory gene |
03/30/1994 | EP0588881A1 3'-end blocked oligonucleotides |
03/30/1994 | CN1084563A Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
03/29/1994 | US5298614 Molecular size distribution of rebonucleic acid |
03/29/1994 | US5298489 DNA sequences recombinant DNA molecules and processes for producing lipocortins III, IV, V and VI |
03/29/1994 | US5298422 Myogenic vector systems |
03/23/1994 | EP0588564A1 Device and method for affinity separation |
03/23/1994 | EP0587749A1 Compositions and delivery systems for transdermal administration of neutral oligomers |
03/23/1994 | EP0386229B1 Support-bound oligonucleotides |
03/22/1994 | US5296350 Ion triggered alkylation of biological targets by silyloxy aromatic agents |
03/18/1994 | CA2106224A1 Bcl-1 locus nucleic acid probes and assay methods |
03/17/1994 | WO1994005813A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
03/17/1994 | WO1994005804A1 Maspin, a novel serpin with tumor suppressing activity |
03/17/1994 | WO1994005790A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
03/17/1994 | WO1994005789A1 Glucagon receptors |
03/17/1994 | WO1994005786A1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells |
03/17/1994 | WO1994005785A1 Multicistronic expression units and their use |
03/17/1994 | WO1994005691A1 Cd27 ligand |
03/17/1994 | WO1994005690A1 Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
03/17/1994 | WO1994005688A1 4,7-dichlorofluorescein dyes as molecular probes |
03/17/1994 | WO1994005333A1 Oligonucleotide modulation of cell adhesion |
03/17/1994 | WO1994005268A1 Novel triplex forming oligonucleotides and methods for their use |
03/17/1994 | CA2143748A1 Oligonucleotide modulation of cell adhesion |
03/17/1994 | CA2143678A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
03/17/1994 | CA2143417A1 Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
03/17/1994 | CA2143188A1 Maspin, a novel serpin with tumor suppressing activity |
03/16/1994 | EP0587298A2 Nucleic acid sequence amplification method |
03/16/1994 | EP0587266A1 Nucleic acid sequence amplification method, composition and kit |
03/16/1994 | EP0586618A1 The use of nucleic acid analogues in diagnostics and analytical procedures. |
03/16/1994 | EP0586570A1 Backbone modified oligonucleotide analogues |
03/16/1994 | EP0586520A1 Backbone modified oligonucleotide analogs |
03/16/1994 | EP0586474A1 Peptide nucleic acids |
03/16/1994 | CN1024021C Herbicid resistance plant consisting glutathione S-transferase |
03/16/1994 | CA2078256A1 Synthesis of sulfide-linked di-or oligonucleotide analogs and incorporation into antisense dna or rna |
03/15/1994 | US5294538 Enzyme inhibitor |
03/15/1994 | US5294533 Detection of food poisoning bacteria, bacterial meningitis |
03/15/1994 | CA1327762C Dna constructs containing a kluyveromyces alpha-factor leader sequence for directing secretion of heterologous polypeptides |
03/09/1994 | EP0585399A1 Treatment of colorectal carcinoma with antisense oligonucleotides to c-myb proto-oncogene |
03/09/1994 | CN1083527A Recombinant entomopoxvirus |
03/08/1994 | US5292875 Method of synthesizing sulfurized oligonucleotide analogs |
03/08/1994 | US5292873 Nucleic acids labeled with naphthoquinone probe |
03/03/1994 | WO1994007538A1 ANTISENSE OLIGONUCLEOTIDES TO B-m^_y^_b^_ PROTO-ONCOGENE |
03/03/1994 | WO1994004694A1 Endothelial lineage specific transcriptional regulatory element from tek |
03/03/1994 | WO1994004688A2 Cationic peptides and method for production |
03/03/1994 | WO1994004674A1 Human melanocyte stimulating hormone receptor |
03/03/1994 | WO1994004557A1 Immunomodulatory peptides |
03/03/1994 | WO1994004552A1 Opioid receptor genes |
03/03/1994 | WO1994004550A1 Cholesteryl-modified triple-helix forming oligonucleotides and uses thereof |
03/03/1994 | WO1994004548A1 Chemically reversible aptamers |
03/03/1994 | WO1994004171A1 Immunomodulatory peptides |
03/03/1994 | WO1994004137A1 Antisense oligonucleotides to cyclin d1 proto-oncogene |
03/03/1994 | WO1994001446A3 Derivatized organic solid support for nucleic acid synthesis |
03/03/1994 | WO1993015205A3 Synthetic haemophilus influenzae conjugate vaccine |
03/03/1994 | DE4328329A1 Freeze-dried polysaccharide bio-matrix useful as pharmaceutical or cosmetic carrier - comprises mixt. of natural and modified material e.g. pectin, alginate, agar, cellulose ether deriv. etc. |
03/03/1994 | CA2143336A1 Tissue specific transcriptional regulatory element |
03/03/1994 | CA2142306A1 Cationic peptides and method for production |
03/03/1994 | CA2142305A1 Opioid receptor genes |
03/02/1994 | EP0584845A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer |
03/02/1994 | EP0584229A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND |
03/02/1994 | EP0584145A1 PROCESS FOR THE $i(IN VITRO) DIAGNOSIS OF CHROMOSOMAL ANOMALIES CORRELATED WITH CMT1A DISEASE |
03/01/1994 | US5290925 Detectable marking for automatic analysis |
03/01/1994 | CA1327328C Bacterial enzymes |
02/26/1994 | CA2104649A1 Antisense compounds complementary to hcv genome |
02/22/1994 | US5288607 Polypeptides having a β-adrenergic receptor activity in man, implicated in the lipolytic response, nucleic acids coding for these polypeptides and the use of these polypeptides for the screening of a substance active on these polypeptides |
02/22/1994 | US5288464 Peptide synthesis |
02/22/1994 | CA1327169C Labeling by simultaneous ligation and restriction |
02/17/1994 | WO1994003637A1 Method for introducing defined sequences at the 3' end of polynucleotides |
02/17/1994 | WO1994003633A1 Assessment of trans-acting factors allelic variation |
02/17/1994 | WO1994003618A1 K. lactis transaldolase gene promoter and use thereof |
02/17/1994 | WO1994003614A1 Inhibitor resistant serine proteases |
02/17/1994 | WO1994003611A2 Ptp-d subfamily of protein tyrosine phosphatases |
02/17/1994 | WO1994003597A1 Peptides inhibiting ras protein activity, preparation and use thereof |
02/17/1994 | WO1994003594A1 Androgen regulation with dna sequences of rat probasin gene |
02/17/1994 | WO1994003472A1 Nucleic acid sequence amplification |
02/17/1994 | WO1994000473A3 Pentavalent synthesis of oligonucleotides containing stereospecific alkylphosphonates and arylphosphonates |
02/17/1994 | WO1994000472A3 Trivalent synthesis of oligonucleotides containing stereospecific alkylphosphonates and arylphosphonates |
02/17/1994 | CA2141847A1 Ptp-d subfamily of protein tyrosine phosphatases |
02/17/1994 | CA2141450A1 Method for introducing defined sequences at the 3' end of polynucleotides |
02/17/1994 | CA2141061A1 Peptides inhibiting ras protein activity, preparation and use thereof |
02/17/1994 | CA2140902A1 K. lactis transaldolase gene promoter and use thereof |
02/16/1994 | EP0583050A2 Recombinant stimulating factor of the neu receptor |
02/15/1994 | US5286717 Inhibitors for replication of retroviruses and for the expression of oncogene products |
02/15/1994 | CA1327002C Elaboration of host defense mediators into biological fluids by systemic dsrna treatment |
02/15/1994 | CA1327001C Topically active compositions of double-stranded rnas |
02/15/1994 | CA1326999C Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function |
02/09/1994 | EP0582244A2 Yeast strains with impaired N-glycosylation |
02/09/1994 | EP0581938A1 Mutation detecting method using photobridging-stabilised double-stranded dna denaturation gradient electrophoresis. |
02/09/1994 | EP0581906A1 ABROGATION OF VIRAL RESISTANCE TO NUCLEOSIDE ANALOGUES BY DOUBLE-STRANDED RNAs |
02/09/1994 | EP0581848A1 Closed sense and antisense oligonucleotides and uses thereof |
02/09/1994 | EP0343227B1 Selective removal of immune complexes |
02/03/1994 | WO1994002637A1 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure |